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Summary
Background: The labile state of short-term memory has been
known for more than a century. It has been frequently reported
that immediate postlearning intervention can readily disrupt
newly formed memories. However, the molecular and cellular
mechanisms underlying the labile state of new memory are
not understood.
Results: Using a bump-and-hole-based chemical-genetic
method, we have rapidly and selectively manipulated aCaMKII
activity levels in the mouse forebrain during various stages of
the short-term memory processes. We find that a rapid shift in
the aCaMKII activation status within the immediate 10 min
after learning severely disrupts short-term memory formation.
The same manipulation beyond the 15 min after learning has
no effect, suggesting a critical time window for CaMKII action.
We further show that during this same 10 min time window
only, shifting in CaMKII activation state is capable of altering
newly established synaptic weights and/or patterns.
Conclusion: The initial 10 min of memory formation and long-
term potentiation are sensitive to inducible genetic upregula-
tion of aCaMKII activity. Our results suggest that molecular
dynamics of CaMKII play an important role in underlying syn-
aptic labile state and representation of short-term memory
during this critical time window.
Introduction
Short-term memory is known to be in a highly labile state
before it is transformed into a longer-lasting, more stable
form [1, 2]. Over the past several decades, many experiments
have shown that immediate postlearning electroconvulsive
shock (ECS) can induce retrograde amnesia, indicating the
existence of a time window during which newly formed mem-
ory is in a highly labile state [3]. This labile phase of short-term
memory is thought to be mechanistically distinct from the pro-
tein-synthesis-dependent consolidation phase of long-term
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4These authors contributed equally to this workmemory [4, 5]. Currently, little is known regarding the
temporal dynamics and molecular basis underlying the labile
state of short-term memory.
CaMKII is a molecule that plays a major role in mediating the
NMDA-receptor signaling involved in synaptic plasticity and
formation of associative memories in the brain [6–15]. It is
believed that Ca2+ activates CaMKII through the NMDA
receptor; CaMKII in turn causes the translocation of the holoen-
zyme to postsynaptic density (PSD) and the subsequent reten-
tion via physical binding to the NR2B subunit of the NMDA
receptor at the synapses [16–20]. Autophosphorylation at the
Thr286 site of aCaMKII further enhances its binding affinity to
Ca2+/CaM and prolongs the association of CaMKII at PSD
[16, 21–23]. It has been suggested that the activated CaMKII
at the PSD zone is responsible for potentiating synapses,
probably via synaptic insertion or increasing channel conduc-
tance of the AMPA receptor [24, 25]. Thus, the CaMKII’s persis-
tent ‘‘on’’ state induced by long-term potentiation (LTP) stimu-
lation may allow the CaMKII to serve as a memory device for
information storage [26]. Consistent with this general idea, sev-
eral genetically modified mice carrying null mutations or point
mutations in aCaMKII have exhibited deficits in memory tests
[27, 28].
Inducible and region-specific gene knockout (third-genera-
tion gene knockout) techniques are valuable for molecular
and temporal analysis of biological processes [29, 30]. How-
ever, because the inactivation event occurs at the DNA level,
manifestation of any phenotype depends on the turnover
rate of the existing protein, which may require days or even
weeks. This inherently slow process has excluded precise
investigation of many in vivo biological processes that occur
within minutes and hours, such as short-term memory.
Recently, we have developed an inducible-protein-knock-
out technology by integrating convergent protein engineering
and rational inhibitor design [31, 32]. This method is based on
the bump-and-hole approach that creates a specific interac-
tion interface between a modified protein domain and sensi-
tized inhibitors. By introducing this system into genetically
modified mice, we can readily and specifically manipulate
the activity of a targeted protein, such as CAMKII, in the sub-
region(s) of the brain in freely behaving mice on the time scale
of a few minutes [31, 33]. Here, our combined electrophysio-
logical and behavioral analyses suggest that the molecular
dynamics of aCaMKII underlie the labile state of short-term
memory.
Results
Rapid Manipulation of aCaMKII Activity in the Transgenic
Mouse Forebrain
To investigate the role of CaMKII in regulating the temporal
labile stage of short-term memory during its initial formation,
we used inducible, reversible, and forebrain-specific CaMKII
transgenic mice generated by a bump-and-hole-based chem-
ical-genetic method [31]. Our overall strategy involved trans-
genic overexpression of aCaMKII-F89G transgene, which
encodes aCaMKII with wild-type-like catalytic activity but
carries an extra hidden cavity inside of its ATP-binding pocket
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tively inhibited by a rationally designed, genetically sensitized
small-molecule inhibitor, NM-PP1 [31, 33]. We confirmed the
forebrain specificity of the transgene expression in the off-
spring of our transgenic mice (Figure 1B).
In these transgenic mice, a single intraperitoneal (i.p.) injec-
tion of NM-PP1 (5 mM) is shown to be capable of suppressing
CaMKII-F89G activity in the forebrain regions within 8 min,
consequently bringing the total amount of CaMKII activity in
the transgenic forebrain back to the normal wild-type levels
(Figure 1C). This inhibition is readily reversible in approximately
40 min, as demonstrated both by pharmacokinetics and en-
zyme-activity assay in Tg-F89G mice. This time course fits well
with the measured pharmacokinetics of 3H-labeled NM-PP1
(Figure 1C). Thus, a single i.p. injection of NM-PP1 into freely
behaving transgenic mice can completely suppress aCaMKII-
F89G activity and consistently maintain total CaMKII activity
at the wild-type level between 10 and 40 min after injection.
We used these pharmacokinetics as a guide for manipulating
CaMKII activity in transgenic mice during our behavioral
experiments. Our previous study shows that NM-PP1 has no
effect on wild-type mice [31].
Figure 1. Chemical-Genetic Manipulation of CaMKII Activity in the Mouse
Forebrain
(A) The bump-and-hole-based chemical-genetic strategy for rapid manipu-
lation of CaMKII activity in the specific region(s) of the brain. A genetically
sensitized bulky inhibitor can selectively inhibit the mutated CaMKII-
F89G, which carries a hidden cavity inside of ATP-binding pocket. We
expressed this transgene only in the forebrain by using a forebrain-specific
aCaMKII promoter.
(B) In situ hybridization confirms the forebrain-specific expression of
aCaMKII-F89G in the transgenic mouse brain (Tg). A transgene-specific
SV40 probe is used. There is no signal from the wild-type brain (WT).
(C) Rapid inhibition of aCaMKII-F89G in the transgenic forebrain can be
achieved by i.p. injection of the bulky inhibitor, NM-PP1 (5 mM). A single
i.p. injection can bring the excessive aCaMKII in the transgenic mice back
to a level approximately comparable to wild-type level between 10 and
40 min after injection. Error bar at 20 min point is small but present.
The total CaMKII activity in the transgenic mice is expressed as the percent-
age of activity in the brains of wild-type littermates. Values are means 6
SEM.Acquisition of Short-Term Memory with Normal
or Elevated CaMKII Activity
To determine whether the activation state of CaMKII plays
a role in the representation of short-term memory in the brain,
we examined individual temporal stages of 1 hr short-term
memory processes. We have chosen three different behavioral
paradigms, namely novel-object-recognition memory, contex-
tual-fear memory, and cued-fear memory. All behavioral
experiments were performed on the littermate wild-type and
transgenic mice and conducted by the two and/or three
experimenters blind to the genotype of each mouse.
We first conducted the novel-object-recognition short-term
memory tests (with 1 hr retention) in transgenic aCaMKII-
F89G mice and their littermate controls. Animals were allowed
to explore two objects in an open field for 15 min. One of the two
objects was replaced with a novel one 60 min later, and the
mice were allowed to explore them for 5 min. The memory per-
formance was evaluated by the time spent on the novel objects.
We allowed learning to occur in the temporally restricted
presence of elevated CaMKII (no NM-PP1 inhibition), which is
known to change plasticity-frequency responses in the trans-
genic brain [31]. A single i.p. injection can provide consistent
and complete in vivo inhibition of aCaMKII-F89G activity in
the transgenic mice between 8 and 35 min after injection and
partial inhibition during the initial 3–8 min as well as during
the last 35–40 min after injection [31]. Therefore, we designed
a two-injection protocol so that we could suppress aCaMKII-
F89G activity for more than 60 min. Immediately after the train-
ing session was completed (within 10–30 s), we administered
the first i.p. injection of NM-PP1; we administered the second
injection 30 min after the first injection so that we could sup-
press aCaMKII-F89G in transgenic mice throughout the rest
of the experiments (including at the time of recall, conducted
at the end of 1 hour retention). The temporally restricted pres-
ence of overexpressed CaMKII-F89G kinase activity in the
transgenic mice during the learning stage (without NM-PP1 in-
hibition) is indicated by a black bar above the timeline at the top
of Figure 2. Under this ‘‘learning-with-elevated-CaMKII’’ para-
digm, we found that transgenic mice showed normal acquisi-
tion and retention of the memory in comparison to that of
wild-type littermate mice (Figure 2A). This suggests that the
elevation of forebrain CaMKII activity during learning does
not impair the acquisition of short-term recognition memory.
We then conducted the learning-with-elevated-CaMKII
experiments with fear conditioning tasks. Mice were given a
pairing of a tone with a mild foot shock, and memory perfor-
mance was evaluated as the percentage of time spent on freez-
ing in response to the same training chamber (contextual freez-
ing) or to the same tone with a different testing chamber (cued
freezing) 60 min after training. Again, we found that transgenic
mice with the transient CaMKII-F89G expression during learn-
ing exhibited normal performance in comparison to their
wild-type littermates in either the 1 hr short-term contextual
memory test (Figure 2B) or cued memory test (Figure 2C).
Thus, the transgenic mice can learn normally regardless
whether they have the normal (with NM-PP1 treatment) or
higher amount (without NM-PP1 treatment) of CaMKII activity
during the acquisition phase.
Next, we asked whether the transgenic mice can acquire
and retain short-term memory when CaMKII-F89G is present
not only during learning, but also during the following 55 min
until memory is recalled. This ‘‘learning/retention-with-ele-
vated-CaMKII’’ paradigm would allow us to further determine
whether the continuous presence of CaMKII-F89G kinase
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with Elevated CaMKII
(A–C) Under this ‘‘learning-with-elevated-
CaMKII’’ paradigm, the temporally restricted
presence of aCaMKII-F89G activity during learn-
ing did not impair memory acquisition and 1 hr
retention as measured by three distinct memory
tasks. The black bar on the top indicates the du-
ration for the presence of aCaMKII-F89G activity.
Animals were trained without any drug treatment.
Immediately after training, they received the first
i.p. injection of NM-PP1. The second i.p. injection
was administered 30 min later. The CaMKII activ-
ity of the transgenic mice during the memory test
was measured to be approximately 98.2% 6
3.8% of that of wild-type mice after receiving
two NM-PP1 injections.
(A) Indistinguishable performance in the novel-
object-recognition test between Tg (n = 12) and
wild-type mice (n = 12) (p > 0.05).
(B) Indistinguishable performance in contextual
conditioning between wild-type (n = 12) and
transgenic mice (n = 12) (p > 0.05).
(C) Cued conditioning in the same groups of
mice. No significant difference was found be-
tween the two groups (p > 0.05). All values are
mean 6 SEM. One-way ANOVA-Tukey was
used for all the statistical analyses.
(D–F) Under this ‘‘learning/retention-with-ele-
vated-CaMKII’’ paradigm, transgenic mice with
temporally restricted expression of aCaMKII-
F89G activity during acquisition and 55 min after
training exhibited normal performance in the
three tests. The black bar on the top indicates
the duration for the presence of elevated aCaM-
KII activity. NM-PP1 was injected 10 min before
recall. The CaMKII activity of the transgenic
mice at the time of 1 hr retention tests were esti-
mated to be about 102.5%6 6.3% of that of wild-
type control mice under this injection protocol.
(D) Normal performance in novel-object-recognition test in transgenic mice with NM-PP1 inhibition (n = 10, p > 0.05), compared with that in wild-type mice
receiving vehicle (n = 10, p > 0.05) or wild-type mice with NM-PP1 inhibition (n = 11, p > 0.05).
(E) Normal performance in contextual conditioning in transgenic mice with NM-PP1 (n = 10, p > 0.05), compared with wild-type mice with vehicle (n = 10,
p > 0.05) or wild-type mice with NM-PP1 (n = 11, p > 0.05).
(F) Normal performance in cued conditioning in transgenic mice with NM-PP1 treatment (n = 10, p > 0.05), compared with wild-type mice with vehicle (n = 10,
p > 0.05) or wild-type mice with NM-PP1 inhibition (n = 11, p > 0.05). All values are mean 6 SEM. One-way ANOVA-Tukey was used for all the statistical
analyses.activity during this period alters short-term memories. Similar
to their performance in the learning-with-elevated-CaMKII
paradigm, transgenic mice showed normal acquisition and re-
tention of the visual memory in comparison to that of wild-type
littermate mice in the novel-object-recognition test (Figure 2D).
Moreover, behavioral performances of transgenic mice in the
1 hr contextual (Figure 2E) and cued retention tests (Figure 2F)
were also indistinguishable from those of their wild-type litter-
mates. Therefore, the persistent presence of CaMKII-F89G
in the forebrain during learning and postlearning retention
periods did not affect memory formation.
Disruption of Short-Term Memory by Shifting Learned
Synaptic States
To investigate whether a postlearning shift in CaMKII activity
disrupts neural representation of short-term memory, we
trained a group of transgenic mice under conditions in which
aCaMKII-F89G activity was unmasked immediately after
memory acquisition (<5 min), and we allowed aCaMKII-F89G
enzymatic activity to be expressed between the initial 5 and
35 min (see the black bar on top of Figures 3A–3C, which
indicates the duration of the availability of aCaMKII-F89G).We first conducted this ‘‘unmasking-CaMKIIF89G-immedi-
ately-after-learning’’ protocol with the novel-object-recogni-
tion test. We observed that such an upward shift severely
disrupted 1 hr retention of recognition memory (Figure 3A;
ANOVA F(1,9) = 38, p < 0.001). Similarly, we found the profound
retention deficits in the short-term contextual-fear memory
test (Figure 3B; ANOVA F(1,11) = 12.29, p < 0.01) as well as
the short-term cued-fear memory test (Figure 3C; ANOVA
F(1,11) = 13.95, p < 0.01). The data suggest that short-term
memory seems to be maintained in a synaptically labile state
that is highly sensitive to postlearning numerical increase in
CaMKII activity.
To further determine the duration of this CaMKII-mediated
labile period of short-term memory, we designed the experi-
ments in which aCaMKII-F89G activity was permitted to be
active only between 10 and 40 min after training (see the black
bar on top of Figures 3D–3F) so that a normal amount of
CaMKII activity was present in the transgenic mice during
memory acquisition, the initial 10 min after training, 40–
60 min after training, and recall. Again, we found that such an
‘‘unmasking-CaMKIIF89G-within-10-minutes-after-learning’’
protocol also caused profound deficits in the retentions of the
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F89G Activity Is Capable of Disrupting the Main-
tenance of One-Hour Short-Term Memory
(A–C) The black bar on the top indicates the
duration for the presence of aCaMKII-F89G activ-
ity; unmasking of activated CaMKII activity
occurred within 5 min after learning. The animals
were given first i.p. drug injection 25 min before
novel-object-recognition training (which lasted
15 min in duration) or 35 min before fear condi-
tioning (4 min in duration). The second injection
was given 30 min before retention tests. The
CaMKII activity of the transgenic mice at the
time of 1 hr retention tests was estimated to be
approximately 100.7% 6 8.1% of that of wild-
type littermates.
(A) Novel-object- recognition memory was
severely disrupted by the early-stage unmasking
of aCaMKII-F89G activity in transgenic mice
(10 animals in each group, F(1,9) = 38, p < 0.001).
(B) Although there is no significant difference
between the two groups in immediate freezing,
a significantly lower freezing response during
the 1 hr contextual retention test was found in
transgenic mice (n = 10) in comparison to that
of wild-type mice (n = 10, F(1,11) = 12.29, p < 0.01).
(C) Although there is no significant difference
between two groups in pre-tone freezing, a signif-
icantly lower freezing response in the 1 hr cued
retention test was found in transgenic mice
(n = 10) in comparison to that of wild-type mice
(n = 10, F(1,11) = 13.95, p < 0.01).
(D–F) Unmasking of aCaMKII-F89G 10 min after
learning is capable of disrupting the maintenance
of short-term memory. The black bar on the top
indicates the duration for the presence of
aCaMKII-F89G activity. The animals were given
i.p. NM-PP1 injection 20 min before novel-ob-
ject-recognition training or 30 min before fear conditioning. The second i.p. injection was given 30 min before recall. The CaMKII activity of the transgenic
mice at the time of 1 hr retention tests were estimated to be about 101.5% 6 6.2% of that of wild-type mice.
(D) Novel-object-recognition memory was severely disrupted by unmasking aCaMKII-F89G activity 10 min after learning in transgenic mice (10 animals in
each group, F(1,18) = 31.4, p < 0.01).
(E) Disruption of contextual-fear memory in transgenic mice by the early-stage unmasking aCaMKII-F89G activity. Although there is no significant difference
between two groups in immediate freezing, a significantly lower freezing response during the 1 hr contextual retention test was found in transgenic mice
(n = 10) in comparison to that of wild-type mice (n = 10) (F(1,18) = 39.76, p < 0.01).
(F) Disruption of cued-fear memory in transgenic mice by the early-stage unmasking aCaMKII-F89G activity. Although there is no significant difference
between two groups in pre-tone freezing, a significantly lower freezing response in the 1 hr cued retention test was found in transgenic mice (n = 10) in com-
parison to that of wild-type mice (n = 10) (F(1,18) = 27.03, p < 0.01). All values are mean6 SEM. One-way ANOVA-Tukey was used for all the statistical analyses
(**p < 0.01).novel-object-recognition (Figure 3D; ANOVA F(1,18) = 31.4,
p < 0.01), contextual-fear (Figure 3E ANOVA F(1,18) = 39.76,
p < 0.01), and cued-fear memories (Figure 3F; ANOVA F(1,18) =
27.03, p < 0.01).
Next, we carried out additional temporal analysis and
designed the ‘‘unmasking-CaMKIIF89G-within-15-minutes-
after-learning’’ protocol in which aCaMKII-F89G activity would
be unmasked only between 15 and 45 min after training (see
the black bar on top of Figures 4A–4C). Under this protocol,
we observed that the transgenic mice showed normal reten-
tions in the novel-object-recognition (Figure 4A), contextual-
fear (Figure 4B), and cued-fear memory tests (Figure 4C).
These experiments suggest that there is a critical time window
(<15 min) during which short-term memories are sensitive to
disruption by upward shift in CaMKII, and they also suggest
that removal of NM-PP1 inhibition of aCaMKII-F89G activity
beyond this time window can no longer disrupt short-term
memories.
Finally, we conducted a set of ‘‘unmasking-CaMKIIF89G-25-
minutes-after-learning’’ experiments in which aCaMKII-F89Gactivity was made available selectively between 25 and
55 min after training (see the black bar on top of Figures 4D–
4F). Once again, we found that late-stage removal of aCaM-
KII-F89G inhibition did not produce detrimental effects on the
retentions in the novel-object-recognition (Figure 4D), contex-
tual-fear (Figure 4E), and cued-fear memory tests (Figure 4F).
These results demonstrate that the critical time window of
the CaMKII-mediated labile period for three types of short-
term memory is restricted to the initial 10 min after learning.
Temporal Dynamics of CaMKII in Hippocampal
Long-Term Potentiation
To determine the effects of molecular dynamics of activated
aCaMKII-F89G on synaptic plasticity, we measured LTP in
the Schaffer collateral pathway with extracellular field record-
ings in CA1 regions of hippocampus in both transgenic and
control slices. We found that single tetanus (100 Hz, 1 s)
evoked larger LTP in transgenic slices in comparison to that
in control slices (Figure 5A, ANOVA F(1,19) = 5.259, p < 0.05).
This enhanced LTP can be reduced to the wild-type level by
Current Biology Vol 18 No 20
1550Figure 4. Unmasking of aCaMKII-F89G 15 Min-
utes and Beyond after Learning Did Not Disrupt
the Short-Term Memory
(A–C) The black bar on the top indicates the dura-
tion for the presence of uninhibited CaMKII-F89G
activity, starting 15 min after learning. Mice were
given i.p. injection 15 min before novel-object-
recognition training or 25 min before fear condi-
tioning. The second injection was given 25 min
before retention tests. The CaMKII activity of
the transgenic mice at the time of 1 hr retention
tests were estimated to be about 92.9% 6 5.9%
of that of wild-type mice.
(A) Normal novel-object-recognition memory in
transgenic mice in which unmasking aCaMKII-
F89G activity took place 15 min after learning
(12 animals each group, p > 0.05).
(B) Normal contextual memory in both wild-type
(n = 10) and transgenic mice (n = 12). No signifi-
cant differences were found in either immediate
freezing or contextual conditioning between the
two groups (p > 0.05).
(C) Normal cued-fear memory in the same groups
of mice. No significant differences were found
(p > 0.05).
(D–F) Unmasking of aCaMKII-F89G 30 min after
learning did not disrupt the short-term memory.
The black bar on the top indicates the duration
for the presence of uninhibited aCaMKII-F89G.
Mice were given NM-PP1 i.p. injection 5 min be-
fore object-recognition training or 15 min before
fear conditioning. The second injection was given
10 min before retention test. The CaMKII activity
of the transgenic mice at the time of 1 hr retention
tests was estimated to be about 95.4%6 4.5% of
that of wild-type mice.
(D) Normal novel-object-recognition memory in
transgenic mice after the late-stage (>25 min af-
ter training) unmasking of aCaMKII-F89G activity
(12 animals each group, p > 0.05).
(E) Normal contextual memory in both wild-type (n = 10) and transgenic mice (n = 12). No significant differences were found in either immediate freezing or
contextual conditioning between the two groups (p > 0.05).
(F) Normal cued-fear memory in the same groups of mice. No significant differences were found (p > 0.05). All values are mean 6 SEM. One-way ANOVA-
Tukey was used for all the statistical analyses.the application of NM-PP1 (5 mM) in the recording chamber
throughout the experiments (Figure 5B). Interestingly, postte-
tanus application of NM-PP1 had no effect on LTP levels in
transgenic hippocampal slices (Figure 5C; ANOVA F(1,26) =
4.692, p < 0.05), suggesting that once CaMKII is activated by
LTP, inhibition of CaMKII activity could not readily reverse
the phosphorylation-triggered downstream events [14, 34].
We then asked whether aCaMKII-F89G remains in a confor-
mationally active state after tetanic stimulation (e.g., binding
with Ca2+/CaM triggers translocation of the CaMKII to the
PSD zone) [16, 22, 23]. We reasoned that if aCaMKII-F89G is
locked in an active conformation during this transient period,
quick removal of NM-PP1 immediately after tetanus would
unmask the ‘‘conformationally activated’’ CaMKII-F89G activ-
ity and subsequently shift the established population LTP to
a higher level. To test this idea, we designed an experimental
protocol in which the hippocampal slices were treated with
NM-PP1 for a fixed duration, starting 10 min before the tetanus
and continuing for an additional 5 min after the tetanus before
being washed out. Interestingly, we found that such a manipu-
lation shifted the otherwise normal-level LTP to a higher level in
transgenic slices (Figure 6A; ANOVA F(1,18) = 6.072, p < 0.05).
To further examine the duration of this critical time window,
we conducted another set of the recording experiments with
a similar protocol, except the drug was washed out at 10 minafter tetanus. Again, we observed the similar effect in shifting
LTP to a higher level (Figure 6B; ANOVA F(1,17) = 5.166, p <
0.05), although we noticed that the level of shift seemed to be
smaller than that of the 5 min washout experiments. Next, we
conducted additional sets of recording experiments in which
the washout was carried out 15 min after tetanic stimulation.
This time, no shift could be produced in the transgenic slices
(Figure 6C). Furthermore, we observed no effect of unmasking
aCaMKII-F89G activity on the established LTP if NM-PP1 was
washed out 30 min after tetanus stimulation (Figure 6D).
Therefore, these results together have demonstrated that the
early-stage removal of NM-PP1 within the temporally restricted
critical time window (%10 min) after stimulation could readily
unmask conformationally activated aCaMKII-F89G activity,
leading to upward shifts in the population level or network pat-
tern of synaptic potentiation. This finding suggests that the mo-
lecular and temporal dynamics of CaMKII play a crucial role in
controlling the early labile phase of synaptic potentiation.
Discussion
A half century ago, Hebb and Gerard proposed a dual-trace
theory of memory, suggesting that short-term memory traces
are represented in a labile and short-lasting neural state before
transforming into long-term memory [1, 2]. Their proposals
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KII-F89G Leads to Larger LTP in Transgenic Mice
(A) A single tetanus (100 Hz, 1 s) evoked large LTP
in transgenic slices in comparison to that in con-
trol slices (p < 0.001, 8 transgenic mice, 11 slices;
8 control mice, 10 slices).
(B) NM-PP1 (5 mM) reduced LTP in transgenic
slices back to normal level (p > 0.05, 8 transgenic
mice, 11 slices; 8 control mice, 11 slices).
(C) Posttetanus application of NM-PP1 (5 mM)
had no effect on the magnitude of LTP in trans-
genic slices (p < 0.001, 11 transgenic mice,
17 slices; 10 control mice, 16 slices). All values
are expressed as mean6 SEM. ANOVA-Tukey was used to determine the statistical difference in the magnitude of LTP from last 10 min block of recordings
(51–60 min) between transgenic and control slices. The black bars in B–C indicate the duration of NM-PP1 treatment.have led to numerous studies, which show that postlearning
administration of electroconvulsive shock, brain impact, trau-
matic injury, and seizures appear to preferentially disrupt
short-term memories, whereas those same types of interven-
tions leave long-term memory largely intact.
We have chosen three different forms of short-term memory
tests for the analysis of the molecular and synaptic mechanism
underlying the labile period of newly formed memory. All these
behavioral tests involve a single training session, and memory
acquisitions are dependent on the NMDA receptors [33, 35–
38]. More importantly, the novel-object-recognition memory
tends to only last for several days, whereas contextual- and
cued-fear memories can last for months and even years,
thereby providing an opportunity to compare the initial stages
of these memory processes known to have distinct durations.
In addition, these three behavioral tests are known to involve
different neuronal circuits. Thus, these different behavioral
paradigms have allowed us to measure and directly compare
whether the initial labile states of those short-term memories
share any commonality.
Using these tasks, we systematically switched on and off the
transgenically expressed aCaMKII-F89G activity in freely be-
having mice and asked how the shift of CaMKII activity alters
short-term memory. Our experiments demonstrate that the
initial 10 min period represents the critical time window during
which both potentiated synapses and short-term memory are
in an especially labile state and are sensitive to numerical
increases in CaMKII activity.
What temporal dynamics of activated CaMKII might underlie
this critical time window? On the basis of the available litera-
ture, it seems that dynamics of CaMKII translocation to and
disassociation from the PSD could underlie what we observed
at the synaptic and behavioral levels (Figure 6E). During this
PSD-association period, removal of NM-PP1 inhibitor from
transgenic CaMKII-F89G ATP-binding pocket can unmask
the activated CaMKII-F89G activity, leading to a rapid shift of
synaptic weight from the existing state to a new state. Such
a switch of synaptic patterns in a given neural network would
then disrupt the ongoing memory representation. However,
once the CaMKII complex is disassociated from the PSD,
unmasking of aCaMKII-F89G activity no longer causes any
significant alteration in the patterns of potentiated synapses
and neurons, thereby having no disruptive effects on short-
term memory representation. There are at least two factors
that may control the dissociation of CaMKII from PSD: (1) sec-
ondary phosphorylation on Thr305/306 of CaMKII, which is
reported to promote disassociation of the enzyme from PSD
[20, 22], and (2) dephosphorylation at the Thr286 site by phos-
phatase 1 action because both PP1 inhibitor and T286D mu-
tant delayed the dissociation of CaMKII from PSD [22], whichsuggests that the dephosphorylation of the autonomous phos-
phorylation site T286 is required for dissociation. Consistent
with our results, the studies in cultured neurons indicate that
the disassociation of CaMKII complex from PSD occurs within
minutes [22, 23].
Although we have demonstrated that numerical increase in
activated CaMKII activity can lead to changes in the estab-
lished LTP level, we currently do not know whether such
changes were due to increased single-channel conductance
of AMPA receptors at these synapses [24], increased insertion
of AMPA receptors [25, 39], or activation of other proteins,
such as those postulated to be involved in the ‘‘synaptic tag-
ging’’ process [40–42]. If potentiation of individual synapses
is an ‘‘all-or-none’’ process [43], the upward shift in population
LTP by unmasking aCaMKII-F89G at PSD could be a result of
an increase in the total numbers of potentiated synapses (net-
work patterns of activated synapses). On the other hand, if
potentiation of individual synapses is a graded process, the
upward shift in LTP would come from an increase in the degree
of potentiation in the same set of synapses.
It is important to point out that although the measurement of
experimental form of synaptic plasticity from the hippocampus
of CaMKII-F89G transgenic mice is informative, we do not
know whether and how such changes in synaptic plasticity
measured in hippocampal slices (e.g., at 28C) reflect in vivo
synaptic changes induced by natural learning (at 37C).
Moreover, it would be useful to further examine the role of
endogenous aCaMKII function with a knockin method (such
as replacing one or both copies of the aCaMKII gene with
aCaMKII-F89G). One traditional approach to the study of
endogenous gene function is to perform knockout experi-
ments. However, in the case of CaMKII, once activated, this en-
zyme quickly phosphorylates its downstream substrates. This
means that pharmacological inhibition or genetic knockout at
this stage will be too late to reverse its consequences, which
can only be reversed by phosphates over time. On the contrary,
the further upregulation of CaMKIIF89G activation can still alter
the downstream signaling process in a rapid manner, thereby
revealing important insights about CaMKII dynamics and
function. The fact that both heterozygous and homozygous
aCaMKII knockouts, as well as several transgenic overexpres-
sors [15, 27, 28, 44], all produced some types of memory-
impairment phenotypes further supports the notion that the
delicate balance between CaMKII and phosphates is crucial
for normal memory function. Our present study provides
a novel insight into this previously unrecognized role in
maintaining short-term memory process.
It is interesting to mention that learning involved in those
three types of behavioral tasks is likely to involve many differ-
ent brain regions; we have not yet examined directly whether
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1552Figure 6. Temporal Dynamics of the Activated aCaMKII-F89G during LTP in the Schaffer Collateral CA1 Pathway in Transgenic Mice
(A) LTP in transgenic slices was shifted to a higher level from the otherwise normal level when NM-PP1 was washed out 5 min after tetanus (p < 0.05, 8 trans-
genic mice, 10 slices; 8 control mice, 10 slices).
(B) LTP in transgenic slices was also shifted to a higher level when NM-PP1 was washed out 10 min after tetanus (p < 0.05, 8 transgenic mice, 10 slices;
8 control mice, 10 slices).
(C) No shift was observed when NM-PP1 was washed out 15 min after tetanus (8 transgenic mice, 11 slices; 8 control mice, 11 slices).
(D) No shift was observed when NM-PP1 was washed out 30 min after tetanus (8 transgenic mice, 11 slices; 8 control mice, 11 slices). All values are
expressed as mean6 SEM. ANOVA-Tukey was used to determine the statistical difference in the magnitude of LTP from the last 10 min block of recordings
(51–60 min) between transgenic and control slices. The black bars indicate the duration of NM-PP1 treatment.
(E) Schematic drawing illustrates the molecular dynamics of CaMII at activated synapses. During the initiation phase, learning triggers the activation of the
NMDA receptor, which permits Ca2+ influx, leading to the binding of Ca2+/calmodulin to CaMKII, which initiates the dissociation of CaMKII from F-actin
(through bCaMKII-mediated action) and then translocation of the complex to PSD. The aCaMKII-F89G-containing holoenzyme in the transgenic animals
is capable of translocating to PSD in the presence of NM-PP1 inhibition because the translocation is an autophosphorylation-independent step. Once trans-
located to PSD via binding to NR2B C-terminal, the active CaMKII potentiates synapses and activates ‘‘synaptic tags.’’ During this PSD-associated phase,
changes in CaMKII activity (such as unmasking the activated aCaMKII-F89G activity) will lead to resetting of the patterns of potentiated synapses in the
network. The dissociation of CaMKII from PSD would make the synapse less vulnerable to the unmasking effect of aCaMKII-F89G activity. The dissociation
may be controlled by the dephosphorylation on T286 by phosphatase 1, secondary phosphorylation at inhibitory phosphorylation sites of aCaMKII, and/or
bCaMKII activity.
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curred in other forebrain regions (such as the amygdala or cor-
tex) of our transgenic mice. Nonetheless, our data consistently
suggest that a switch between the normal state and higher
state in terms of CaMKII-activity level within a certain time win-
dow can severely disrupt memory formation [31, 33]. It is im-
portant to point out that our previous study has shown that
constitutive presence of aCaMKII-F89G during learning and
retention periods has no significant effect on memory perfor-
mances on transgenic mice [31]. This suggests that as long
as consistency in CaMKII activity is maintained, learning and
consolidation can still occur normally in the brain, even with
elevated CaMKII activity and heightened LTP levels. However,
alteration in CaMKII level during the first postlearning week
disrupts long-term memory consolidation. Furthermore, our
more recent study also shows that bCaMKII is also involved
during the memory consolidation [33]. Taken together with
our present findings, we conclude that memory process is
sensitive to numerical changes in CaMKII activity at multiple
time windows. It would be of great interest to examine how
the rapid changes in CaMKII activation affect neural-network
patterns and dynamics during the encoding of episodic
memories [45–47], especially given the observation that
aCaMKII overexpression at the time of recall can lead to rapid
erasure of the memory being retrieved [48].
In conclusion, using the rapid inducible and reversible
chemical-genetic technique, we have shown that the initial
10 min of new-memory formation and LTP are sensitive to
manipulation of aCaMKII activation state. We conclude that
CaMKII activation state plays an important role in regulating
synaptic-potentiation dynamics and short-term memory
representation.
Experimental Procedures
Production and Biochemical Characterizations of Transgenic Mice
The transgenic mice were produced and maintained on the BCF1 hybrid
background [31]. The genotype and the expression pattern of the transgene
were determined by in situ hybridization with the same protocol [31]. We de-
termined the NM-PP1 pharmacokinetics by using both a radioactive-tracing
method and a kinase-activity assay [31]. The time course of single NM-PP1
inhibition on CaMKII from pharmacokinetic studies served as a guideline for
the short-term memory analysis. A single i.p. injection of NM-PP1 seems to
provide effective inhibition between 10 and 40 min after injection. To ensure
the valid NM-PP1 inhibition in vivo, we also measured the off rate of NM-PP1
that may occur during the brain dissection procedure. By carrying out a
serial dilution (1:10, 1:100) to the brain homogenates, we found no signifi-
cant dilution effect on the binding of NM-PP1 on CaMKII in the above assay
condition. In addition, we also performed kinase assay to confirm the effec-
tive inhibition of CaMKII-F89G activity by NM-PP1 in the transgenic mice re-
ceiving the double injection protocols, which were designed to compensate
for the rebound of CaMKII-F89G activity after 40 min of a single injection.
The specific suppression of CaMKII-F89G activity in those mice receiving
double i.p. NM-PP1 injections was listed in the figure legends of 1 hr
short-term memory results.
We also measured NM-PP1 pharmacokinetics synthesizing 3H-labeled
NM-PP1 [31]. The injected solution contains the mixture of cold NM-PP1
and 3H-NM-PP1 at the ratio of 1:100. 10 ml of the body weight of NM-PP1
mixture was i.p. injected into the mice. At each time point, mice were
sacrificed, and their forebrains were quickly dissected and weighted. The
forebrain tissues were homogenized in 1 3 ice-cold PBS. 200 ml of the
homogenate was put into 4 ml of scintillation solution for measurement of
radioactivity. The data presented were the percentage of CPM reading
from the total forebrain homogenate compared with that of the total amount
of NM-PP1 injected into the body.
Hippocampal-Slice Recording
The recording procedures were the same as previously described [8, 28, 31].
In brief, transverse slices of the hippocampus from transgenic and wild-typelittermate mice (3–4 months old) were rapidly prepared and maintained in
a submerge chamber at 28C. 5 mM of NM-PP1 was perfused in the indi-
cated slices. A bipolar tungsten stimulating electrode was placed in the
striatum radiatum in the CA1 region, and extracellular field potentials were
recorded with a glass microelectrode (3–12 MU filled with ACSF), also in
the striatum radiatum. Test responses were elicited at 0.017 Hz. In the ex-
periments involving NM-PP1 treatments, the control slices (from wild-type
littermates) received the same drug treatment as the transgenic slices
during those LTP measurements.
Behavioral Measurements
Mice were maintained in a temperature-controlled environment on a 12 hr
light-dark cycle. Adult male CaMKII F89G transgenic and wild-type litter-
mate mice (2–4 month old) were used throughout all behavioral tests. For
NM-PP1 treatment, the dose of 16.57 ng per gram of body weight per mouse
was used via i.p. injection (5 mM). NM-PP1 was dissolved in DMSO, with a
final concentration of 0.02% of DMSO in the solution. All the control animals
(wild-type littermates) received the same drug treatment as the transgenic
animals during the behavioral experiments.
Novel-Object-Recognition Task and Fear Conditioning
Those behavioral experimental protocols were the same as described pre-
viously [8, 29, 36]. For the novel-object-recognition test, a preference index,
a ratio of the time spent exploring any one of the two objects (training ses-
sion) or the novel one (retention session) over the total time spent exploring
both objects, was used to measure recognition memory. For fear condition-
ing, the freezing responses were recorded in a sampling time of 5 s. Data
were calculated as mean 6 SEM. One-way ANOVA-Tukey was used for all
the statistical analyses.
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